Shandong Science

   

Study on the anti-inflammatory mechanisms of Cyperi Rhizoma based on network pharmacology, molecular docking, and animal experiments

SHAO Shuqin  FAN Wenshuai  WANG Zilong  LIU Kechun  ZHANG Shanshan*   

  1. Institute of Biology, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250103, China
  • Received:2026-03-04 Accepted:2026-05-06 Published:2026-11-04 Online:2026-11-04
  • Contact: ZHANG Shanshan E-mail:zhangss@sdas.org

Abstract: To investigate the anti-inflammatory activity and mechanism of Cyperi Rhizoma, network pharmacology was used to identify its active components and anti-inflammatory targets. Based on a zebrafish model and transcriptome sequencing, the anti-inflammatory activity and mechanism of Cyperi Rhizoma extracts were further validated. Subsequently, animal experiments and molecular docking were conducted to clarify the anti-inflammatory effects of core components and their potential targets. Network pharmacology identified core anti-inflammatory components (e.g., sugeonyl acetate and isorhamnetin) and targets (e.g., STAT3 and AKT1), involving the PI3K-Akt, MAPK, and other signaling pathways. Animal experiments confirmed that Cyperi Rhizoma extracts, as well as isorhamnetin, quercetin, and kaempferol, significantly inhibited the migration of immune cells in zebrafish, increased SOD activity, and reduced the production of NO and ROS. These effects were further enhanced following vinegar processing (P < 0.01). Transcriptome analysis indicated that the anti-inflammatory mechanism of Cyperi Rhizoma is closely associated with regulation of the ferroptosis pathway, significantly affecting the expression of ferroptosis-related genes (slc40a1, fth1, gpx4a/b, lpcat3, pcbp2) and inflammation-related genes (il8, il0, akt1, stat3) (P < 0.01 or P < 0.05). α-Cyperone, cyperenone, isorhamnetin, quercetin, and kaempferol significantly inhibited immune cell migration in zebrafish (P < 0.01), with flavonoid components showing stronger binding affinity toward LPCAT3, STAT3, and FTH1. Cyperi Rhizoma may exert its anti-inflammatory effects by acting on the core targets LPCAT3, STAT3, and FTH1 through synergistic regulation of multiple components, thereby inhibiting ferroptosis, alleviating oxidative stress, and ultimately reducing inflammation.

Key words: Cyperi Rhizoma, anti-inflammatory; zebrafish, network pharmacology, transcriptome, molecular docking, ferroptosis

CLC Number: 

  • R285

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits third parties to freely share (i.e., copy and redistribute the material in any medium or format) and adapt (i.e., remix, transform, or build upon the material) the articles published in this journal, provided that appropriate credit is given, a link to the license is provided, and any changes made are indicated. The material may not be used for commercial purposes. For details of the CC BY-NC 4.0 license, please visit: https://creativecommons.org/licenses/by-nc/4.0